Walleye Trading LLC Madrigal Pharmaceuticals, Inc. Transaction History

Walleye Trading LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$60.57 - $79.51 $238,403 - $312,951	3,936 New	3,936 $256,000
Q1 2022 May 16, 2022	SELL	$55.89 - $101.89 $51,362 - $93,636	-919 Reduced 36.47%	1,601 $157,000
Q4 2021 Feb 14, 2022	BUY	$72.34 - $95.09 $182,296 - $239,626	2,520 New	2,520 $214,000
Q4 2020 Feb 16, 2021	SELL	$110.06 - $133.7 $176,096 - $213,919	-1,600 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$99.78 - $124.21 $151,166 - $188,178	1,515 Added 1782.35%	1,600 $190,000
Q2 2020 Aug 14, 2020	BUY	$60.13 - $125.71 $5,111 - $10,685	85 New	85 $10,000
Q4 2018 Feb 14, 2019	SELL	$94.77 - $215.54 $4,359 - $9,914	-46 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$207.3 - $300.31 $9,535 - $13,814	46 New	46 $10,000

297

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.37B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.